Barbara J.
- Country
- Poland
- Department
- Zakład Medycyny Nuklearnej i Endokrynologii Onkologicznej Centrum Wsparcia Badań Klinicznych
Research Overview
- Long-Term Extension Study of Imeroprubart in Adult Patients With Graves' Disease
- Evaluation of Cabozantinib in Radioiodine-Refractory Differentiated Thyroid Cancer Post-VEGFR-Targeted Therapy: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Batoclimab Efficacy and Safety in an Open-Label Extension Study for Thyroid Eye Disease Treatment in Participants Completing IMVT-1401-3201/3202
Data & Insights
Has run more than one trial at 48 of 129 partner sites.
Specializations
Thyroid Cancer Treatment
The investigator specializes in treating various forms of thyroid cancer, with particular expertise in medullary thyroid cancer and its advanced manifestations.
- RET-mutant medullary thyroid cancer
- Metastatic thyroid conditions
- Radioiodine-refractory differentiated thyroid cancer
Focuses on innovative therapeutic approaches for progressive and advanced thyroid malignancies.
Targeted Therapies
Demonstrates extensive experience in evaluating novel targeted treatments for thyroid disorders, particularly focusing on kinase inhibitor therapies.
- Selpercatinib applications
- Cabozantinib treatment protocols
- Vandetanib therapeutic approaches
Specializes in comparing effectiveness of different therapeutic agents for advanced thyroid conditions.
Thyroid Eye Disease
Conducts research in the treatment of Thyroid Eye Disease (TED), with specific interest in innovative biological therapies.
- Batoclimab treatment evaluation
- Proptosis management
- Long-term disease control
Explores maintenance therapy approaches for thyroid-related ocular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.